Autolus Therapeutics (AUTL) Profit After Tax (2017 - 2025)
Historic Profit After Tax for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$79.1 million.
- Autolus Therapeutics' Profit After Tax rose 363.22% to -$79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.8 million, marking a year-over-year increase of 1681.34%. This contributed to the annual value of -$220.7 million for FY2024, which is 590.21% down from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Profit After Tax is -$79.1 million, which was up 363.22% from -$47.9 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Profit After Tax ranged from a high of $34.0 million in Q3 2021 and a low of -$242.5 million during Q4 2021
- For the 5-year period, Autolus Therapeutics' Profit After Tax averaged around -$48.3 million, with its median value being -$45.6 million (2023).
- The largest annual percentage gain for Autolus Therapeutics' Profit After Tax in the last 5 years was 8889.23% (2022), contrasted with its biggest fall of 22678.3% (2022).
- Autolus Therapeutics' Profit After Tax (Quarter) stood at -$242.5 million in 2021, then surged by 88.89% to -$26.9 million in 2022, then crashed by 186.53% to -$77.2 million in 2023, then soared by 64.24% to -$27.6 million in 2024, then plummeted by 186.66% to -$79.1 million in 2025.
- Its last three reported values are -$79.1 million in Q3 2025, -$47.9 million for Q2 2025, and -$70.2 million during Q1 2025.